1:Quanduzhong capsule

3 trials

Sponsors

Institute of Basic Theory for Chinese Medicine,China Academy of Chinese Medicine Science, Xiyuan Hospital CACMS, Beijing Hospital of Traditional Chinese Medicine

Conditions

Essential hypertensionEssential hypertension (nephrasthenia syndrome)

Phase 4

Clinical Study for Quanduzhong Capsule in Treating Essential Hypertension: A Randomized Controlled Trial

RecruitingChiCTR1900021699

Xiyuan Hospital CACMSEssential hypertension

Start: 2019-03-11Updated: 2019-03-11

Clinical Pre-experiment for Post-market Reevaluation of Quanduzhong Capsule

Active, not recruitingChiCTR1900021690

Institute of Basic Theory for Chinese Medicine,China Academy of Chinese Medicine ScienceEssential hypertension (nephrasthenia syndrome)

Start: 2018-10-28Updated: 2020-04-20

A multi-center, randomized, double-blind, double-simulated, and positive-drug parallel-controlled clinical study to evaluate the effectiveness and safety of Quanduzhong capsule in treating essential hypertension&

Active, not recruitingITMCTR2100004710

Beijing Hospital of Traditional Chinese MedicineEssential hypertension (nephrasthenia syndrome)

Start: 2021-06-30Updated: 2023-02-20

Related Papers

Quanduzhong capsules for the treatment of grade 1 hypertension patients with low-to-moderate risk: A multicenter, randomized, double-blind, placebo-controlled clinical trial

Frontiers in Pharmacology2023-01-108 citations